Compare Expensify Inc (EXFY) vs Veritone Inc (VERI) Price & Performance

Expensify (EXFY) trades at $1.77, down 2.21% on the day, with a bullish technical signal from moving averages but mixed earnings history. Revenue for 2025 was $142.10M, but the company posted a net loss of -$21.39M, with negative profit margins and ROE. Recent news highlights product innovations like AI-powered expense automation and a $25M stock buyback program, indicating active management efforts to drive growth and shareholder value.

The outlook remains challenging due to persistent unprofitability, though positive cash flow from operations and strategic partnerships offer some stability. Investment opportunities hinge on successful execution of new AI and travel billing initiatives to improve margins. Key risks include intense competition in expense management software and the company's ability to achieve sustained profitability amid fluctuating revenues.

Veritone (VERI) stock trades at $1.04, down 2.8% on the day, reflecting significant fundamental challenges. The company reported a net loss of $111.73M on $92.19M revenue for 2025, with a negative net margin of -123.76%. Technical indicators are mixed but lean bearish, with moving averages signaling a downtrend. Recent news is dominated by multiple class-action lawsuits alleging securities fraud related to revenue overstatements, with a key deadline of July 20, 2026.

The outlook is clouded by severe financial losses, ongoing litigation, and negative profitability metrics. While a high gross margin of 68.52% and a low P/S ratio of 0.86 present a potential value case, the extreme negative ROE of -349.36% and substantial cash burn from operations pose critical risks. Analyst consensus is split, but the overwhelming negative sentiment from recent legal news creates a highly uncertain investment environment.